Writing Science

Some scientists would call writing the most excruciating part of their jobs. Others would say it's an act of joy, or at least it doesn't cause great pain. For a small cadre, writing for audiences outside of their peers--the communications that generally don't count toward promotion and tenure--is also a second career. To be sure, writing for the popular press is nothing new in science. Veteran scientist-authors such as Carl Sagan were profiled in The Visible Scientists,1 a book that was p

Written byKaren Young Kreeger
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Some scientists would call writing the most excruciating part of their jobs. Others would say it's an act of joy, or at least it doesn't cause great pain. For a small cadre, writing for audiences outside of their peers--the communications that generally don't count toward promotion and tenure--is also a second career.

To be sure, writing for the popular press is nothing new in science. Veteran scientist-authors such as Carl Sagan were profiled in The Visible Scientists,1 a book that was published more than two decades ago. These researchers and many more are attracted to writing for general audiences in various outlets--books, magazine articles, newspaper columns, encyclopedias, educational CDs--for many reasons.

"The motivation is a very sincere desire to get the word [about discoveries] beyond the academy out into the culture," says Angela von der Lippe, a senior editor with W.W. Norton & Co. in New York. "Oftentimes the language ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies